Site Search | NIAMS

Enter a phrase above to search files and articles within the site.

Typically materials that are more than 5 years old will be archived

Displaying 1 - 19 of 19 results

NIAMS Involvement in the Accelerating Medicines Partnership® (AMP®)

https://www.niams.nih.gov/grants-funding/funded-research/accelerating-medicines

This public-private partnership seeks to develop new ways of identifying and validating promising biological targets for diagnostics and drug development.

Discussing Bone, Muscle, Skin, & Autoimmune Diseases: Info for American Indians, Alaska Natives - audio

https://www.niams.nih.gov/newsroom/spotlight-on-research/discussing-bone-muscle-skin-autoimmune-diseases-info-american

A conversation between Dr. David R. Wilson, director of the NIH Tribal Health Research Office, and Dr. Lindsey A. Criswell, director of NIAMS, about information and resources for American Indians and Alaska Natives related to bone, muscle, skin, and autoimmune diseases.

Roundtable Discussion on Lupus with Congresswoman Lee

https://www.niams.nih.gov/about/meetings-events/visits/roundtable-discussion-lupus-congresswoman-lee

Video of a Facebook Live discussion on lupus research, treatment, and care, moderated by Rev. Cheryl Ward and featuring experts in the field.

Understanding Autoimmune Diseases

https://www.niams.nih.gov/understanding-autoimmune-diseases

Sometimes, your immune system makes mistakes. If it sees your body’s healthy cells as a threat, it may attack them. This can cause an autoimmune disorder.

A Biological Betrayal

https://www.niams.nih.gov/biological-betrayal

Dr. Kaplan has studied a number of autoimmune diseases, from rheumatoid arthritis to vasculitis, but most of her efforts have been focused on what she calls “the poster child” for autoimmune diseases: systemic lupus erythematosus (SLE), more commonly referred to as ‘lupus.’

Laura B. Lewandowski, M.S., M.D.

https://www.niams.nih.gov/about/directory/laura-b-lewandowski-ms-md

Dr. Lewandowski leads a team of scientists studying the genetics of early-onset systemic lupus erythematosus patients in populations around the globe. Her research focuses on genetic drivers of severe disease and inflammation in diverse cohorts worldwide.

Sarthak Gupta, M.D.

https://www.niams.nih.gov/about/directory/sarthak-gupta-md

Sarthak Gupta M.D., is a Rheumatologist and an Assistant Research Physician in Lupus clinical trials.

Casting the NET Wide: How Neutrophils Shape Chronic Autoimmune and Inflammatory Diseases

https://www.niams.nih.gov/casting-net-wide-how-neutrophils-shape-chronic-autoimmune-and-inflammatory-diseases

Known as the “disease with a thousand faces,” systemic lupus erythematosus is a lifelong autoimmune disease with a wide range of symptoms and signs—fatigue, fever, joint pain, facial rash and skin lesions, shortness of breath, and more. It may develop suddenly or slowly and be mild or severe, with people affected going through periods of flare up and remission of their symptoms.

New treatment shows promise in reducing the risk of cardiovascular disease in people with lupus

https://www.niams.nih.gov/newsroom/spotlight-on-research/new-treatment-shows-promise-reducing-risk-cardiovascular-disease

Researchers have identified a potential treatment to reduce the risk of cardiovascular disease in people with systemic lupus erythematosus (SLE), a chronic autoimmune disease.

Exercise Energizes Patients With Autoimmune Disease

https://www.niams.nih.gov/exercise-energizes-patients-autoimmune-disease

Recently, a small IRP study showed that exercise training can help reduce the debilitating fatigue that often accompanies the autoimmune disease known as lupus, and also illuminated some of the underlying mechanisms that may lead to those benefits.

Mariana J. Kaplan, M.D.

https://www.niams.nih.gov/about/directory/mariana-j-kaplan-md

Dr. Kaplan’s research focuses on identifying the molecular mechanisms that promote the initiation and perpetuation of perturbed immune responses and the development of organ damage and premature vascular disease in systemic autoimmunity.

Systemic Lupus Erythematosus (Lupus)

https://www.niams.nih.gov/health-topics/lupus

What is systemic lupus erythematosus (lupus)? Systemic lupus erythematosus (lupus) is a chronic (long-lasting) autoimmune disease that can affect many parts of the body, including the: Skin. Joints. Heart. Lungs. Kidneys. Brain. Lupus happens when the immune system, which normally helps protect the body from infection and disease, attacks its own tissues. This attack causes inflammation and, in some cases, permanent tissue damage. If you have lupus, you may have times of illness (flares) and times of wellness (remission). Lupus flares can be mild to serious, and they do not follow a pattern. However, with treatment, many people with lupus

Ichthyosis

https://www.niams.nih.gov/health-topics/ichthyosis

What is ichthyosis? Ichthyosis is a group of skin disorders. It leads to dry, itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but sometimes the disease can affect internal organs, too.

Clinical and Investigative Orthopedics Surgery Unit

https://www.niams.nih.gov/labs/bhattacharyya-lab

Led by Dr. Timothy Bhattacharyya, the unit investigates orthopedic conditions, including femur fractures and hip infections, and related treatments.

Laboratory of Muscle Stem Cells and Gene Regulation

https://www.niams.nih.gov/labs/sartorelli-lab

Led by Dr. Vittorio Sartorelli, the lab studies mechanisms that regulate specification, differentiation, and regeneration of skeletal muscle cells.

Systemic Autoimmunity Branch

https://www.niams.nih.gov/labs/kaplan-lab

Led by Dr. Mariana Kaplan, the branch studies autoimmune diseases, like lupus and rheumatoid arthritis, seeking treatments and improved outcomes.

New clues on tissue damage identified in rheumatoid arthritis and lupus

https://www.niams.nih.gov/newsroom/press-releases/new-clues-tissue-damage-identified-rheumatoid-arthritis-and-lupus

Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into tissue damage for these autoimmune conditions. Findings include the identification of novel molecular signatures related to immune system signaling in kidney cells that may reflect their active role in disease process; molecular targets, including specific white blood cells, for potential treatment in lupus nephritis; and specific types of fibroblasts and white blood cells that are involved in rheumatoid arthritis.

Scientists Pinpoint Traitorous Immune Cells in Lupus

https://www.niams.nih.gov/scientists-pinpoint-traitorous-immune-cells-lupus

Scientists can distinguish between highly similar cell types using cutting-edge laboratory procedures. Using such techniques, IRP researchers have identified a particular variety of cell in a specific stage of its life cycle as a primary culprit behind the autoimmune disease known as lupus.

Muscle Disease Section

https://www.niams.nih.gov/labs/mammen-lab

Led by Dr. Andrew Mammen, the unit researches human muscle diseases, as well the basic biology of skeletal muscle regeneration.